New IV combo aims to stop chemo sickness in kids

NCT ID NCT06904235

First seen Apr 13, 2026

Summary

Chemotherapy often causes nausea and vomiting, which is especially hard for children. This study tests a new IV drug called NEPA (fosnetupitant/palonosetron) to prevent these side effects in kids with cancer. The trial has two parts: first, an open-label phase to find the right dose and check safety, then a double-blind phase comparing NEPA to standard anti-nausea drugs. About 95 children from birth to under 18 years old will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • "AHEPA" University General Hospital of Thessaloniki, 2nd Department of Pediatrics

    RECRUITING

    Thessaloniki, Greece

  • Aghia Sophia Children's Hospital, Pediatric Hematology/ Oncology Unit (POHemU)

    RECRUITING

    Athens, Greece

  • Ankara University Faculty of Medicine Children's Hospital, Department of Children Oncology and Hematology

    RECRUITING

    Ankara, Mamak, Turkey (Türkiye)

  • Clinic of Pediatrics, Oncology and Hematology University Pediatric Center them M. Konopnicka SP ZOZ Central Clinical Hospital Medical University of Lodz

    RECRUITING

    Lodz, Poland

  • Clinical Department of Paediatric Oncology and Haematology VOIVODSHIP SPECIALIST CHILDREN'S HOSPITAL them. prof. dr. Stanisław Popowski in Olsztyn

    WITHDRAWN

    Olsztyn, Poland

  • Department of Oncology Institute "Monument - Child Health Center"

    RECRUITING

    Warsaw, Poland

  • Department of Oncology and Surgical Oncology for Children and Youth Institute Mother and Child

    RECRUITING

    Warsaw, Poland

  • Department of Paediatrics and Paediatric Haemato-Oncology University Clinical Hospital No. 1 them. prof. Tadeusz Sokołowski Pomeranian Medical University

    WITHDRAWN

    Szczecin, Poland

  • Department of Paediatrics, Haematology, Oncology and Rheumatology Voivodship Children's Hospital them. J. Brudziński

    RECRUITING

    Bydgoszcz, 85-667, Poland

  • Department of Paediatrics, Oncology and Paediatric Immunology, University Clinical Hospital No. 1 them. prof. Tadeusz Sokołowski Pomeranian Medical University in Szczecin

    RECRUITING

    Szczecin, Poland

  • Department of Pediatric Oncology, Hematology and Transplantation Clinical Hospital them. Karol Jonscher Medical University them. Karol Marcinkowski in Poznań

    RECRUITING

    Poznan, Poland

  • Department of Pediatrics, Oncology and Hematology University Children's Clinical Hospital them. Ludwik Zamenhof in Bialystok

    WITHDRAWN

    Bialystok, Poland

  • Emergency Children's Hospital " Louis Turcanu, Oncology-Haematology and BMP department

    RECRUITING

    Timișoara, Romania

  • Erciyes University Hospitals Kanka Children's Hematology Oncology and Bone Marrow Hospital

    RECRUITING

    Kayseri, Melikgazi, Turkey (Türkiye)

  • Fundeni Clinical Institute, Pediatric Hematology and BMT

    RECRUITING

    Bucharest, Romania

  • Gazi University Gazi Hospital Children Hematology and Oncology

    RECRUITING

    Ankara, Turkey (Türkiye)

  • Hacettepe University Hospitals Oncology Hospital 2nd Floor Children Oncology

    RECRUITING

    Ankara, Turkey (Türkiye)

  • Istanbul University Istanbul Faculty of Medicine Topkapı

    NOT_YET_RECRUITING

    Istanbul, Faith, Turkey (Türkiye)

  • Oncology Institute "Prof. Dr. Al. Trestioreanu", Pediatric Oncology

    RECRUITING

    Bucharest, Romania

  • University Children'S Hospital in Lublin, Department of Pediatric Hematology, Oncology, and Transplantology

    NOT_YET_RECRUITING

    Lublin, 20-093, Poland

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

IV NEPA (fosnetupitant/palonosetron)

What this could lead to

If successful, this could provide a more effective way to prevent chemotherapy-induced nausea and vomiting in children, improving their quality of life during cancer treatment.

What could go wrong

This is an early-phase study with only 95 participants, so results may not apply to all children. The drug may cause side effects or not work better than existing treatments.

Conditions

The condition(s) this trial relates to.

cancer chemotherapy-induced toxicity Nausea Vomiting

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.